Shima M - Search Results

1

Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A.

Matsui H, Fujimoto N, Sasakawa N, Ohinata Y, Shima M, Yamanaka S, Sugimoto M, Hotta A. Matsui H, et al. Among authors: shima m. PLoS One. 2014 Aug 15;9(8):e104957. doi: 10.1371/journal.pone.0104957. eCollection 2014. PLoS One. 2014. PMID: 25126862 Free PMC article.

2

Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting.

Tanaka I, Yoshioka A, Shima M, Fujiwara T, Terada S, Nakai H, Sawamoto Y, Kamisue S, Fukui H. Tanaka I, et al. Among authors: shima m. Int J Hematol. 1991 Dec;54(6):523-30. Int J Hematol. 1991. PMID: 1724392

3

Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A.

Fukui H, Yoshioka A, Shima M, Tanaka I, Koshihara K, Fukutake K, Fujimaki M. Fukui H, et al. Among authors: shima m. Int J Hematol. 1991 Oct;54(5):419-27. Int J Hematol. 1991. PMID: 1756252 Clinical Trial.

4

Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated hemophilia A patients treated with recombinant factor VIII. Kogenate Japanese Clinical Study Group.

Shima M, Sawamoto Y, Nakai H, Kamisue S, Murakami T, Morichika S, Tanaka I, Hayashi K, Yoshioka A. Shima M, et al. Int J Hematol. 1995 Jul;62(1):35-43. doi: 10.1016/0925-5710(95)00378-6. Int J Hematol. 1995. PMID: 7670006 Clinical Trial.

5

The use of porcine factor VIII in Japan.

Yoshioka A, Shima M, Morichika S, Terada S, Fukui H. Yoshioka A, et al. Among authors: shima m. Semin Hematol. 1994 Apr;31(2 Suppl 4):26-8. Semin Hematol. 1994. PMID: 7939769 Clinical Trial. No abstract available.

6

[Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].

Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A. Shima M, et al. Rinsho Ketsueki. 1996 Nov;37(11):1303-8. Rinsho Ketsueki. 1996. PMID: 8960666 Japanese.

7

Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.

Sawamoto Y, Shima M, Tanaka I, Nakai H, Kamisue S, Scandella D, Yoshioka A. Sawamoto Y, et al. Among authors: shima m. Int J Hematol. 1997 Feb;65(2):151-8. doi: 10.1016/s0925-5710(96)00555-5. Int J Hematol. 1997. PMID: 9071819

8

Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.

Matsui H, Sugimoto M, Tsuji S, Shima M, Giddings J, Yoshioka A. Matsui H, et al. Among authors: shima m. J Pediatr Hematol Oncol. 1999 Jan-Feb;21(1):74-6. J Pediatr Hematol Oncol. 1999. PMID: 10029819

9

Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis.

Nogami K, Shima M, Giddings JC, Hosokawa K, Nagata M, Kamisue S, Suzuki H, Shibata M, Saenko EL, Tanaka I, Yoshioka A. Nogami K, et al. Among authors: shima m. Blood. 2001 Feb 1;97(3):669-77. doi: 10.1182/blood.v97.3.669. Blood. 2001. PMID: 11157483 Free article.

10

Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease.

Matsumoto T, Shima M, Fukuda K, Nogami K, Giddings JC, Murakami T, Tanaka I, Yoshioka A. Matsumoto T, et al. Among authors: shima m. Thromb Res. 2001 Dec 15;104(6):381-8. doi: 10.1016/s0049-3848(01)00385-1. Thromb Res. 2001. PMID: 11755947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

926 results

Search Page

Filters